Replies to post #3933 on Biotech Values

[DewDiligence]

>> Don't forget DNDN for Gleason<7. <<

DNDN’s prostate trial is one of the very few follow-on trials in a subset where I consider the underlying medical hypothesis strong enough to expect a reasonable chance of success.

Most subset trials are really just fishing expeditions.